An interventional study of Simulation-Based Postpartum Hemorrhage Training in Postpartum Hemorrhage and Simulation Based Medical Education, sponsored by Mehmet Kırıköz. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 24 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by Mehmet Kırıköz · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 45 studies in Postpartum Hemorrhage with a site in Turkey — 4 open to participants now, 5 under way, none of them phase 3. Postpartum Hemorrhage · Turkey.
Among the 45 studies in Postpartum Hemorrhage with a site in Turkey, this one is the 34th largest by planned enrollment of the 35 interventional ones that give a count, is one of 3 that started in 2026, is one of 30 with no phase, and was the 39th registered.
471 studies on the registry are indexed under Postpartum Hemorrhage; 76 are open to participants now.
Browse Postpartum Hemorrhage studies →4 of the 45 studies in Postpartum Hemorrhage with a site in Turkey are open now. Recruiting first, the newest first:
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi · Sites in Turkey
Ages 18–35 · Women only · Healthy volunteers
Bagcilar Training and Research Hospital · Sites in Turkey
Ages 18–45 · Women only · Healthy volunteers
Cukurova University · Sites in Turkey
Ages 17–25 · Women only · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 41 Postpartum Hemorrhage studies recruiting now, 21 (51%) set no upper age limit and 20 (49%) stop at 75 or younger; 6 take children under 18; 20 take healthy volunteers.
This study: 24 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
45 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 33 is below the median of 148 across 362 interventional studies indexed under Postpartum Hemorrhage.
Median enrollment 150 across the 35 interventional studies, 88 across the 10 observational. Of the 34 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 45 has an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Mehmet Kırıköz as lead sponsor.
Mehmet Kırıköz has 1 study filed under Postpartum Hemorrhage — fewer than ten, so there is no comparison to draw.
1 of the studies in Postpartum Hemorrhage with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07943052Bagcilar Training and Research HospitalIntrauterine Misoprostol in Cesarean Delivery: Effect on Postpartum Hemorrhage | 2027-06-30 |
Add it to your calendar (.ics) → With an account.
Among the 45 studies in Postpartum Hemorrhage with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective interventional study aims to evaluate the effect of simulation-based postpartum hemorrhage (PPH) training on team performance and crisis resource management skills among senior anesthesiology residents. Participants will undergo a structured high-fidelity simulation training program focused on postpartum hemorrhage management. Performance will be assessed before and after the intervention using validated assessment tools, including crisis resource management scoring systems. The study seeks to determine whether simulation-based training improves clinical decision-making, team communication, and overall performance in obstetric emergencies.
Postpartum hemorrhage (PPH) remains a leading cause of maternal morbidity and mortality worldwide, requiring rapid recognition and effective team-based management. Simulation-based training has emerged as a valuable educational tool to enhance both technical and non-technical skills in high-risk clinical scenarios.
This prospective interventional study is designed to assess the impact of simulation-based postpartum hemorrhage training on team performance and crisis resource management (CRM) skills among senior anesthesiology residents. Participants will take part in a structured high-fidelity simulation program replicating obstetric hemorrhage scenarios.
Performance will be evaluated using validated scoring systems for crisis resource management and team performance, including assessments of leadership, communication, situational awareness, and decision-making. Pre- and post-training evaluations will be conducted to measure the effectiveness of the intervention.
The primary objective is to determine whether simulation-based training improves overall team performance. Secondary outcomes include improvements in communication skills, response time, adherence to clinical protocols, and self-reported confidence levels.
This study aims to contribute to the growing body of evidence supporting simulation-based education in anesthesiology and obstetric emergency management.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will undergo a structured high-fidelity simulation-based training program focused on postpartum hemorrhage management. Performance will be assessed before and after the intervention.
Behavioral: Simulation-Based Postpartum Hemorrhage Training
High-fidelity simulation-based training designed to improve management of postpartum hemorrhage, including crisis resource management skills, team communication, and clinical decision-making.
Change in Crisis Resource Management (CRM) Score
Team performance will be assessed using a validated Crisis Resource Management (CRM) scoring system based on a 5-point Likert scale (1-5). Each item is scored from 1 (poor performance) to 5 (excellent performance), with higher scores indicating better team performance. Scores will be recorded before and immediately after the simulation-based training, and the change in total CRM score will be analyzed.
Time frame: Baseline and immediately after simulation training
Change in Team Performance Score
Team performance will be evaluated using a structured assessment tool focusing on communication, leadership, and coordination during simulation scenarios. The assessment is based on a 5-point Likert scale (1-5), where higher scores indicate better performance. Scores will be recorded before and immediately after the simulation-based training.
Time frame: Baseline and immediately after simulation training
Plan to share: No — Individual participant data (IPD) will not be publicly shared due to institutional policies and the nature of the study. Data may be available from the corresponding author upon reasonable request.
No publications or documents are linked to this record.
Ran from Jul 2026 to primary completion in Sep 2026, 1 month.
Of 112 non-industry interventional studies with no phase under Postpartum Hemorrhage, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 28. This study's 1 month is below that.
Counting every sponsor, half of 119 studies reached it within 16 months; a quarter within 7 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.